NEWSROOM

July 29, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL Telemedicine to appoint David Arnon as CEO of SHL Telemedicine

June 25, 2024

SHL Telemedicine provides an update regarding CEO position

June 20, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL Telemedicine confirms discussions regarding a possible investment in its Israeli activity

May 21, 2024

SHL Telemedicine expands offering in Israel with groundbreakingat-home Biomarker blood test

May 16, 2024

SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch

May 9, 2024

SHL announces Special General Meeting Results

April 17, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL Announces Full-Year 2023 Results – Stable Revenue Growth Alongside Groundbreaking Clinical Milestones

April 11, 2024

Study shows groundbreaking final results for SHL Telemedicine’s SmartHeart® in Post-ACS patient care

April 8, 2024

SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment